CSL and eight other pharmaceutical companies will be forced to cut medicine costs for some US patients following pressure from the Trump administration.
Eighteen months after returning to Australia, Cadillac has struggled to win over local buyers. Now, the US carmaker is banking on its new EV model to break through.
